Publicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (27)

2023

  1. Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells

    EMBO Journal, Vol. 42, Núm. 1

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2021

  1. The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells

    Autophagy, Vol. 17, Núm. 6, pp. 1349-1366

2020

  1. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer

    Journal of Hepatology, Vol. 72, Núm. 1, pp. 125-134

  2. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

2019

  1. c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch

    Stem Cells, Vol. 37, Núm. 8, pp. 1108-1118

2018

  1. An enzymatic system for decolorization of wastewater dyes using immobilized CueO laccase-like multicopper oxidase on poly-3-hydroxybutyrate

    Microbial Biotechnology, Vol. 11, Núm. 5, pp. 881-892

  2. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury

    Liver International, Vol. 38, Núm. 9, pp. 1664-1675

  3. Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

    Redox Biology

  4. Poly-3- hydroxybutyrate functionalization with BioFtagged recombinant proteins

    Applied and Environmental Microbiology, Vol. 84, Núm. 4

2017

  1. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

    Redox Biology, Vol. 13, pp. 94-162

2016

  1. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 604-619

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  4. TGF-β signalling and liver disease

    FEBS Journal, pp. 2219-2232

  5. The rationale for targeting TGF-β in chronic liver diseases

    European Journal of Clinical Investigation, Vol. 46, Núm. 4, pp. 349-361

2015

  1. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 10, pp. 2453-2463

  2. Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection

    Food and Chemical Toxicology, Vol. 80, pp. 298-309

2014

  1. Polμ deficiency increases resistance to oxidative damage and delays liver aging

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells

    PLoS ONE, Vol. 8, Núm. 7